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Abstract 
This paper provides a comprehensive quantitative review of high quality randomized 
controlled trials of psychological therapies for anxiety disorders in children and young 
people.  Using a systematic search for randomized controlled trials which included a 
control condition and reported data suitable for meta-analysis, 55 studies were 
included.  Eligible studies were rated for methodological quality and outcome data 
were extracted and analyzed using standard methods.  Trial quality was variable, 
many studies were underpowered and adverse effects were rarely assessed; however, 
quality ratings were higher for more recently published studies.  Most trials evaluated 
cognitive behavior therapy or behavior therapy and most recruited both children and 
adolescents.  Psychological therapy for anxiety in children and young people was 
moderately effective overall, but effect sizes were small to medium when 
psychological therapy was compared to an active control condition. The effect size for 
non-CBT interventions was not significant.   Parental involvement in therapy was not 
associated with differential effectiveness.   Treatment targeted at specific anxiety 
disorders, individual psychotherapy, and psychotherapy with older children and 
adolescents had effect sizes which were larger than effect sizes for treatments 
targeting a range of anxiety disorders, group psychotherapy, and psychotherapy with 
younger children.  Few studies included an effective follow-up.  Future studies should 
follow CONSORT reporting standards, be adequately powered, and assess follow-up.  
Research trials are unlikely to address all important clinical questions around 
treatment delivery.  Thus, careful assessment and formulation will remain an essential 
part of successful psychological treatment for anxiety in children and young people.    
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Highlights 
 
Meta-analysis of  55 RCTS of psychotherapy for child anxiety disorders.   Treatment 
effect size was moderate overall, small to medium with active control.   Therapy for 
specific disorders had larger effects than generic therapy.  Individual therapy had 
larger effects than group therapy.   Studies need effective follow up, cost effectiveness 
analysis and more power. 
 
 
 
 The cumulative prevalence of anxiety disorders in children is around 10% by 
the age of 16 years (Costello, Mustillo, Erkanli, Keeler, & Angold, 2003).   For a 
large proportion of children anxiety problems are long lasting and interfere with their 
development and functioning (Langley, Bergman, McCracken, & Piacentini, 2004).  
Thus, significant attention has been given to the development and evaluation of 
psychological and pharmacological therapies.  Currently the dominant psychological 
treatment is cognitive behavior therapy (CBT), and in recent years there have been a 
number of systematic reviews and meta-analyses of CBT for anxiety in children and 
adolescents (e.g. Cartwright-Hatton, Roberts, Chitsabesan, Fothergill, & Harrington, 
2004; Compton, March, Brent, Albano, Weersing, & Curry, 2004; Davis, May, & 
Whiting, 2011; In-Albon & Schneider, 2006; Ishikawa, Okajima, Matsuoka, & Yugi, 
2007; James, Soler, & Wetherall, 2005, Silverman, Pina, & Visweran, 2008).  These 
reviews have concluded that effect sizes are moderate.  For example, James et al., 
(2005) calculated effect sizes of -.55 to -.58 depending on the outcome measure used.  
 The field has continued to develop rapidly, both in terms of numbers of trials 
and in the quality of reporting, and to date no meta-analysis has included all 
childhood anxiety disorders and all psychological therapies.  For example, many of 
the meta-analyses above were restricted to certain anxiety disorders, with many 
excluding OCD and PTSD and several excluding specific phobias. However, there are 
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strong arguments to suggest that all anxiety disorders should be included.  Firstly, 
selective exclusion does not allow us to fully explore whether psychotherapy is 
effective for anxiety disorders in children and adolescents. Secondly, there is a great 
deal of co-morbidity among anxiety disorders (Costello, Egger, & Angold, 2005; 
Storch et al., 2008). Thirdly, having wider inclusion criteria means that fewer trials 
must be excluded (e.g. because they had some children with OCD or PTSD in the 
study).  Finally, there are many similarities in underlying theories of these anxiety 
disorders. For example, the perseveration seen in OCD can also be seen in 
pathological worry; the panic response in specific phobias can be seen in social 
anxiety and separation anxiety. 
 CBT for children and adults has developed in parallel (Benjamin et al., 2011).  
Unlike CBT for adults with anxiety disorders, where there has been a proliferation of 
specific treatment models for different anxiety disorders, treatment of child anxiety 
includes programs which are aimed at a range of anxiety disorders as well as disorder 
specific treatment.   For example, the most widely disseminated treatment protocol 
‘Coping Cat’ (Kendall, 1990, Kendall & Hedtke, 2006) is a structured CBT program 
which uses the same anxiety treatment strategies with children who have a range of 
disorders including separation anxiety, social anxiety, specific phobias, OCD, and 
GAD, and who typically present with a number of co-morbid anxiety problems
 Disorder-specific CBT protocols for children and young people have been 
developed for OCD (Derisley, Heyman, Robinson, & Turner, 2008; March & Mulle, 
1998), PTSD, (Cohen, Berliner, & Mannarino, 2000; Smith et al., 2007), social 
phobia (Fisher, Masia-Warner, & Klein, 2004) and specific phobias (Davis, 
Ollendick, & Ost, 2009).  There are some reviews of specific anxiety disorder 
treatments (e.g. OCD; Watson & Rees, 2008); however, it is unclear if these disorder-
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specific treatments are more effective than generic treatment for anxiety in children 
and young people.  Thus one aim of this meta-analysis is to calculate effect sizes 
obtained from trials which have used general or ‘omnibus’ treatments of anxiety, and 
effect sizes from trials which have examined focused treatments for specific anxiety 
disorders.  
 Although CBT is emerging as the dominant treatment method for anxiety 
disorders in children and adolescents, other models of psychotherapy have been 
developed and evaluated in formal randomized trials.  Previous meta-analyses have 
either specifically excluded non-CBT trials (Ishikawa, 2007; James et al., 2005), or 
have failed to identify any non-CBT trials (In-Albon & Schneider, 2007).  Given that 
other models of psychotherapy have the potential to influence clinical practice and 
service development a key aim of this review is to provide an overview of any 
psychological treatments for which evidence is available.  The combination of 
including all anxiety disorders and including all psychotherapies allows this analysis.  
 In addition to direct questions of effectiveness of treatments for child and 
adolescent anxiety disorders we also wish to address a number of supplementary 
questions relating to predictors or moderators of treatment outcome.  Some of these 
questions relate to basic questions about methods of treatment delivery and have 
implications for service development; for example, what is the effect size for 
individual treatment and what is the effect size for group treatment?   Similarly, is the 
number of treatment sessions associated with outcome from psychological therapy?   
Other questions have broader and more theoretically interesting implications 
which are specifically related to the fact that treatments for children and adults have 
significant points of differences which are, in part, related to the specific 
developmental needs of children and young people.   The most obvious point of 
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difference relates to the fact that children and adolescents are less cognitively mature 
than adults.  This has several consequences.  First there is an on-going debate about 
the extent to which cognitive maturity is required for successful engagement in 
cognitive behavioral treatment (e.g. Cartwright-Hatton et al., 2004; Grave & Blisset, 
2004).   Some clinicians and researchers argue that cognitively based interventions are 
not accessible to children and young people because they lack the cognitive maturity 
to engage adequately (e.g. Barrett, 2000).  A typical response to this concern has been 
to target interventions on behavioral rather than cognitive components of treatment 
(Stallard, 2002).   Other clinicians and researchers have argued that children’s 
cognitive development is more flexible and variable, and that with adequate 
adaptations and support many young children can demonstrate the ability to engage in 
the cognitive elements of cognitive behavior therapy (Quakley, Reynolds, & Coker, 
2004) and can benefit from cognitive behavioral treatment (Monga, Young, & Owens, 
2009).  However, there is limited treatment effectiveness research with younger 
children (Cartwright-Hatton et al., 2004), and the question has not been resolved.  
Therefore one aim of this review will be to compare effect sizes associated with 
cognitive behavioral treatment of anxiety for older and younger children. 
 Psychological therapies with children and young people also vary in the extent 
to which they are intended to work with or through parents. Some individual trials 
comparing individual child CBT with CBT which involves family members suggest 
that parental involvement is beneficial (e.g. Wood, Piacentini, Southam-Gerow, Chu, 
& Sigman, 2006), and other studies show that parental involvement is not helpful (e.g. 
Bodden et al., 2008).  Recent meta-analyses of CBT for child anxiety have found no 
differences in effect sizes in trials which included and excluded parents from 
treatment (In-Albon & Schneider, 2007; Ishikawa et al., 2007; James et al., 2005; 
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Silverman, Pina, & Viswesvaran, 2008), and Barmish and Kendall (2005) concluded 
that further research is required before this question can be answered.  
In contrast, a general meta-analysis of the involvement of parents in child 
psychotherapy more generally (Dowell & Ogles, 2010) concluded that parent 
participation was beneficial. However, they found that the added benefit of involving 
parents was smaller in therapies that were cognitive-behavioral in orientation. Dowell 
and Ogles (2010) included psychotherapy for all disorders, and the finding cannot be 
specifically generalized to the treatment of anxiety disorders in children and young 
people.  In the absence of conclusive evidence it is sometimes assumed that treating 
children with the close involvement of their parents is beneficial to treatment outcome 
(e.g. OCD treatment guidelines, National Institute for Health and Clinical Excellence, 
2005).  In this meta-analysis we will examine effect sizes for treatment which 
involves parents and effect sizes for treatments which focus primarily or exclusively 
on working with the child or young person without their parent involved. 
  This meta-analysis therefore has four main aims.  The first is to provide an up 
to date and comprehensive meta-analytic review of high quality randomized 
controlled trials of psychological treatments for a range of anxiety disorders in 
children and adolescents.   Within this we will examine the effect size of cognitive 
behavioral treatments and other psychological treatments.  Second, we will compare 
the effectiveness of generic anxiety treatments with disorder-specific treatments for 
anxiety disorders.  Third, we will examine the effect of child age on effectiveness of 
treatment.  Finally, we will assess the effect of treatment delivery (group vs. 
individual, individual vs. family, number of sessions) on outcome.   
Method 
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For the purposes of this meta-analysis we defined psychotherapy for anxiety 
as an intervention designed to alleviate the symptoms of diagnosed anxiety disorders 
or elevated anxiety levels.  A psychological intervention could take the form of a 
structured or unstructured interaction with a trained professional or a specially 
designed treatment program.  Parent administered treatment programs were also 
included in the analysis when parents were given appropriate clinical supervision. 
 Published meta-analyses have used different methods of selecting studies.  For 
example, the quality criteria used are variable, with some studies using high 
thresholds for inclusion (e.g. formal diagnosis of anxiety disorder required; In-Albon 
& Schneider, 2007; James et al., 2005; minimum number of sessions required; James 
et al., 2005), and others including non randomized treatments and open trials 
(Silverman et al., 2008).  We have adopted quality criteria used by the Cochrane 
collaboration to identify and select studies.  We have included a wide range of trials 
including those in community and mental health settings.  As our review is explicitly 
on psychotherapy for anxiety disorders we have also searched specifically for 
treatment trials which did not include CBT.    
Literature Search 
A systematic search for relevant studies was carried out based on guidelines 
by the Cochrane Depression, Anxiety, and Neurosis group (James, et al., 2005).  
Studies for inclusion in the meta-analysis were located through a variety of methods; 
a) computer searches on PsychINFO and MEDLINE (January 1990-December 2010) 
using keywords and names of key researchers in the area; b) reference lists in relevant 
reviews and papers; c) hand searching journals from 1990 – December 2010 in which 
one or more studies had been identified; d) emails to authors of published trials to 
elicit ‘in press’ publications.  Keywords used were  anxiety, anxious, phobia/s, school 
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refusal, worry, OCD, obsessions, PTSD, trauma, panic, separation with 
child/ren/hood, adoles*, youth/s, young, with treatment, therapy, psychotherapy, 
CBT, behavior/behaviour therapy, IPT, attachment,   Searches were not restricted to 
methodological key words to prevent studies from being omitted due to poor 
indexing.  We limited studies to those published in English and in peer review 
journals.  
Criteria for study inclusion, and resulting pool of studies 
For inclusion in the meta-analysis all studies had to meet the following 
criteria:  
a) participants selected because of elevated anxiety levels, or a formal 
diagnosis of any anxiety disorder (including PTSD, OCD, social anxiety);  
b) randomized allocation of participants into a minimum of one treatment 
condition and one control condition.   
c) all participants in the study were less than 19 years old;  
d) treatment interventions were specifically designed to reduce symptoms of 
anxiety; 
e) means and standard deviations of outcome measures were reported or could 
be deduced from data reported in the paper.   
 The final sample consisted of 55 studies.  These are identified in the reference 
list and summary information concerning individual studies is presented in Table 1.   
(Table 1 about here) 
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Study Coding Procedures 
 We developed two coding schemes; one for data extraction and one for quality 
rating, and data were entered using a standard form for each.  Each study was coded 
by two independent judges (JA and either SR, or CW).  For data extraction we 
identified variables relating to the participants, the study design and methods, and the 
results.  Where discrepancies in judgment occurred the study was jointly reviewed by 
both judges and a unanimous score was given.  All data were entered by a single 
reviewer (JA). 
Data extraction variables. 
Participants. 
Age range of participants.   The mean age and standard deviation of the 
sample was recorded for each experimental group.  Where the information was not 
provided separately by group we used the overall mean and standard deviation.  In 
line with previous meta-analyses (e.g., Weisz, McCarty, & Valeri, 2006; Weisz, 
Weiss, Han, Granger, & Morton, 1995) we classified studies as child, adolescent, or 
mixed.  Studies where participants were 13 and under were classified as ‘child’, 
studies where all participants were over 13 were classified as ‘adolescent’, and studies 
which included participants below and over 13 years were classified as ‘mixed’.   
Gender of participants.  Where possible (i.e. where data were provided) we 
coded the proportion of females in each arm of the trial; where this was not provided 
we coded the overall proportion of females across all arms of the trial. 
Type of anxiety diagnosis.  We coded participants for type of anxiety disorder 
according to the diagnosis made for the trial (almost always on the basis of the ADIS, 
e.g. Brown, Di Nardo, & Barlow, 1994).  Many studies included mixed anxiety 
disorders and co-morbid anxiety disorders were the norm rather than the exception.  
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We also included studies where there was a single diagnostic category (i.e. specific or 
social phobia, OCD, or PTSD) and recorded co-morbid diagnoses.   
Study design and methods: 
 Type of control group.  Studies used different types of control groups. We 
coded control groups into active controls and passive controls (e.g. wait-list and no 
treatment control groups). We defined active control conditions as those where 
participants received a plausible intervention which fell short of a formal 
psychological therapy (e.g. supportive counseling, drug placebo, relaxation, 
bibliotherapy), or was explicitly identified by the authors as a ‘control’ treatment, or 
was implicitly identified as the control condition e.g. by a directional hypothesis. The 
two studies that included a pure bibliotherapy condition (Rapee, et al., 2006, Lyneham 
& Rapee, 2006) were classified as active control conditions as there was no therapist 
input for either parent or child. Studies which explicitly compared two or more active 
treatments where both were presented as equivalent (e.g. two psychotherapy 
treatments or medication vs. CBT) and where neither was identified explicitly or 
implicitly as the control condition, were excluded on the basis that they could not 
provide data for calculating effect sizes for the active treatment condition(s).  The 
calculation of effect sizes requires that the treatment of interest is compared to a 
control treatment.  Trials with multiple arms including an active or passive control 
group (e.g. medication, and psychotherapy, and active and/or passive control 
conditions) were included because the control group data provided the basis for 
estimating the effect size of psychotherapy.  
Outcome measures.  Our primary outcome measure is the child’s or 
adolescent’s self report of anxiety symptoms.   This is for two reasons.  First, we 
consider that if a reliable and valid measure is chosen, children and adolescents are 
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best placed to report on their own internal experiences.  Second, this approach allows 
a broad evaluation of psychotherapy for anxious children and adolescents as it 
excludes fewer trials.  However, using child self report may lead to more conservative 
estimates: reviews that have compared treatment effects reported by child self report 
and parent report have found that child self report leads to smaller effect sizes 
(Ishikawa et al., 2007; Silverman et al, 2008). 
Many studies used more than one measure of self reported anxiety symptoms 
and reported data on all of them with no clear or explicit primary outcome.  The use 
of different outcome measures can lead to difficulties in interpretation (Hutton & 
Williamson, 2000).  To standardize our analysis we made an a priori decision to 
choose one outcome measure in each study.  For trials focusing on a specific anxiety 
disorder we used disorder specific outcome measures.  All treatment trials of OCD 
used the CYBOCS (Children’s Yale-Brown Obsessive Compulsive Scale; Scahill, et 
al., 1997) as an outcome measures so we used this as the outcome for all OCD trials.  
Six of the seven trials for social phobia used the SPAI (Social Phobia and Anxiety 
Inventory for Children; Beidel, Turner, & Morris, 1995) so this was used when 
available for trials of social phobia.  For treatment trials of PTSD there was a wide 
range of measures (9 primary outcome measures over 16 treatment trials for trauma 
and PTSD).  For PTSD studies therefore we chose the measure which targeted PTSD 
symptoms specifically.   
For all other trials the choice of outcome measure was based on the frequency 
with which each measure was used across all the trials in the meta-analysis. Seven 
general measures of anxiety were identified, with some measures being used 
frequently and others rarely. The RCMAS (Revised Child Manifest Anxiety Scale 
(RCMAS; Reynolds & Richmond, 1979) was the most frequently used (19 trials).  
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Therefore we used the RCMAS as the outcome measure when it was available. When 
the RCMAS was not available we used data from the next most frequently used 
measure, the SCAS (Spence Children’s Anxiety Scale, Spence, 1998), used in 8 trials, 
followed by the SCARED (Birmaher et al., 1997), and the FSSC-R (Ollendick, 1983)  
(see table 1 for details). (N.B. many trials used more than one measure and some trials 
of specific anxiety disorders also measured general anxiety symptoms).   
Therapy delivery method.  Treatment delivery was categorized as either group 
or individual.  Treatments in which one or more family members (typically parents) 
were involved in sessions with their individual child / adolescent were coded as 
‘individual’.  Some treatment protocols included group sessions for parents and 
parallel group sessions for children and these were classified as ‘group’ treatments.  
Where there was a mixture of individual family sessions and group family sessions 
the predominant mode of treatment, meaning the mode which took up most sessions, 
was used as the basis of the classification.     
Treatment duration.  Because the mean number of treatment sessions attended 
was not always reported we coded the number of hours spent in therapy as specified 
in the treatment protocol.   
Follow-up.  Follow-up assessments were coded for each study, where data 
were available, for both control and experimental arms of the trial.  For most studies it 
was not possible to code the follow up data because those participants who had been 
included in, for example, a waitlist control group, were offered treatment at the end of 
the active phase of treatment for the experimental group.  Therefore control 
conditions typically ended soon after the end of treatment data had been collected. 
 Parental involvement.  The extent of parental involvement in treatment was 
coded into 4 categories on the basis of the information given in the paper.  
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‘Significant involvement’ was coded where parents were routinely involved in all or 
the majority of treatment sessions.  There were also some treatments where parents 
attended parallel therapy groups to their child and where these were equal in number 
to the sessions delivered to the children.  These were also coded as ‘significant 
involvement’.  ‘Some involvement’ was coded where parents were involved routinely 
in selected sessions but were not expected to attend every sessions or where there 
were parallel parental therapy sessions which were fewer in number than those for 
children.  ‘Minimal involvement’ was coded when parents were involved in a small 
number of sessions (e.g. for psycho-education only) or were invited to join a short 
part of their child’s therapy session to share information with the therapist and ‘check 
in’ on progress.   Some treatment studies specified that parents were not involved in 
treatment and some did not mention the role of parents at all; in these instances 
parental involvement was coded as ‘no parental involvement’. 
Quality coding.  
Each paper was independently rated by two people (CW and SR) using a 
modified version of the 23 item Moncrieff, Churchill, Drummond, & McGuire (2001) 
quality coding system which was designed specifically to assess interventions for 
depression and ‘neurosis’.  The scale reflects specific methodological issues 
associated with mental health treatment studies, and each item is rated on the basis of 
information provided in the published paper. Moncrieff et al., (2001) suggest that 
assessing the quality of treatment trials in mental health requires specific instruments 
which capture some of the specific challenges in this area e.g. reliability and validity 
of assessment instruments, complexity of interventions).  Items are typically rated as 0 
(absent), 1 (partial), or 2 (fully present).  Ratings of 0 (absent) and 2 (present) are 
used for dichotomous variables e.g. ITT analysis).  Items cover basic elements of 
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study design (e.g. randomization method, sample selection, sample size), data analysis 
(e.g. intent to treat analyses), length of follow-up, and presentation of results.  Higher 
total scores reflect better quality studies.  Moncrieff et al. (2001) reported mean 
quality scores of 30 treatment trials in mental health.  Across 3 raters the mean rating 
was between 16.3 (SD, 6.3) and 20.9 (SD, 9.0), and overall inter-rater reliability was r 
= 0.75 to 0.86.  
We made some minor modifications to the coding scheme to reflect that fact 
that we were assessing psychotherapy studies.  Specifically, we did not code the item 
relating to blinding participants to treatment allocation as this is not possible in 
studies of psychotherapy.  In addition we added two new items to indicate if therapy 
was manualized (1 – yes, 0 – not manualized) and if therapy integrity was tested (1 – 
yes, 0 – no assessment of treatment integrity).   
In the current study inter- rater reliability of quality was good (r=.78) and 
similar to Moncrieff et al., (2001).  We examined the relationship between quality of 
studies and effect sizes by correlating the overall total score for each study with the 
effect size for each study, and by comparing funnel plots for all 55 studies and for all 
studies which scored over 30 on the quality rating system.   
Data synthesis. 
  
 We calculated effect sizes using continuous data relating to symptom severity 
on the key outcome measure.  Means and SDs of outcome variables at baseline, end 
of treatment, and (where available) at follow-up, were extracted.  Meta-analysis was 
performed with REVMAN software (version 4.2.10; The Cochrane collaboration, 
Oxford, UK).   Negative values indicated that participants in the treatment group 
reported greater reduction in anxiety than those in the control group; positive values 
indicated that participants in the control group reported greater reduction in anxiety 
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than those in the treatment group.   Because we examined effect sizes for a range of 
different sub-groups the results are presented in summary tables (Tables 2 and 3).  
Funnel plots were used to assess for evidence of bias.  Cochrane’s test for 
heterogeneity was used to determine whether the studies in the meta-analysis were 
evaluating the same underlying sizes of effect.  The decision was made to use random 
effects analysis due to the large and diverse population included in the meta-analysis.  
Due to the various study designs, outcome measures, sample sizes and treatment 
durations, homogeneity could be rejected, therefore negating the possibility of using a 
fixed effect analysis. 
Results 
 We identified 55 randomized controlled trials in which children and/or 
adolescents with anxiety were treated using a psychological therapy (see Table 1).  
Across all studies 2434 children and young people were included in the treatment 
group, and 1824 children and young people were included in the control group.  The 
majority of studies (n = 33) recruited children and young people with a specific 
anxiety disorder (16 PTSD, 7 social phobia, 5 OCD, 3 specific phobias and 2 school 
anxiety), with the rest recruiting children with a variety of anxiety disorders.  Co-
morbidity of anxiety disorders was typical.  Two studies recruited participants with 
autistic spectrum disorders and co-morbid anxiety disorders and adapted CBT 
specifically for the population.  Anxiety disorders are often co-morbid in this 
population.   Forty five studies evaluated CBT as either the only active psychological 
therapy (n=31) or as a comparison with another active psychological therapy (n=17), 
with three studies including both active and passive control conditions.   Because of 
the small number of behavioral therapy studies (n=3) we collapsed these studies with 
studies of cognitive behavior therapy into a single category which we referred to as 
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CBT.  The remaining seven studies evaluated EMDR (n=3), a psychosocial 
intervention (n=1), narrative therapy (n=1), and trauma specific psychotherapy (n=2). 
Most studies (54%) used a group therapy format, with 4 studies (7%) comparing a 
group intervention to an individual intervention.   
Table 1 about here 
Quality ratings of the studies ranged from 19.5 to 43 (mean = 29.9, SD = 
5.19).  All of the studies included in this meta-analysis met minimum methodological 
quality criteria (e.g. used randomization to experimental and control groups).  To 
examine the extent to which methodological quality has changed over time we 
correlated the  year of publication for each trial with the quality rating of each trial; 
this was significant,  r = .44, p = .002, which suggests that methodological quality of 
randomized trials of psychological therapy for child anxiety has improved over time.  
Improvements noted in more recently published studies included adherence to 
CONSORT standards of reporting, the use of concealed randomization, reporting of  
study attrition and drop out, and the use of  intent to treat (ITT) analyses, often 
alongside completer analysis.  A minority of studies stated that they used an ITT 
analysis and in many studies it was not clear if a completer or ITT analysis was used.  
Some aspects of methodological quality were widely ignored; for example, only one 
study specifically addressed and reported possible adverse effects of psychological 
treatment (Walkup et al., 2008). 
Funnel plots were examined of all studies (n=55) and of 27 studies which 
scored above the median for quality.  There was no evidence of publication bias on 
the basis of the funnel plots. 
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What is the Overall Effectiveness of Psychological Therapy for Children and 
Young People with Anxiety? 
First we examined the effect size for all 55 randomized trials of psychotherapy 
for children and/or adolescents with anxiety.  This analysis thus includes CBT and 
other psychological treatments and a mixture of disorder-specific treatments and 
generic anxiety treatments.  Table 2 shows the results of the meta-analysis in relation 
to overall effectiveness of psychotherapy for anxiety disorders.  Across the 55 studies 
the overall effect size of psychotherapy for anxiety was moderate and significant 
compared to the effect size in the control groups.  We next examined the effect size in 
the 39 studies which had used a passive control condition (i.e. a waitlist control 
group) and the 19 studies which used an active control condition (for example 
supportive counselling or psycho-education) (NB: This does not add to 55 because 
three studies used a passive and an active control group). 
Table 2 about here 
 Across the 39 studies with a passive control condition 1617 children were 
allocated to psychotherapy for anxiety and 1170 to a passive control condition.  The 
overall weighted effect size of psychological therapy compared to a passive control 
suggested that psychological treatment for anxiety was effective when compared with 
passive control conditions, and that the effect size was moderate to large. In the 19 
studies which compared psychological therapy for anxiety with an active control 
condition 997 children received psychological therapy and 741 were randomized to 
the active control. For these studies the standardized effect size of psychological 
therapy was small and statistically significant.    
 In the majority of the studies we reviewed CBT was either the only 
psychological therapy evaluated or it was one of a number of arms within a trial.  We 
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therefore calculated the effect size of the seven studies which did not include CBT, all 
of which were for PTSD.  These seven studies included 305 children and young 
people in the treatment conditions and 297 children and young people in the control 
conditions.  The effect size for psychological therapy which was not a variant of CBT 
was not significant (see Table 2).    
Forty-eight studies compared participants who received CBT (N = 2145) to 
participants who received either a passive or active control (N = 1595).   The overall 
effect size for CBT for anxiety was similar to the overall effect size for all 
psychotherapy studies.  Similarly the effect size for the 34 CBT studies which used a 
passive control group was very close to the overall psychotherapy effect size (i.e. 
moderate to large).  The effect size for the 17 CBT studies with an active control was 
small but statistically significant. 
 In the majority of studies participants in the control group were offered access 
to psychological therapy after a pre-determined period of time, which was usually 
equivalent to the length of time for which participants in the experimental group 
received therapy.  Almost all studies included a follow up period but data at that point 
could not be compared to a no-treatment control group because the original control 
group had received treatment.  Therefore true follow up comparisons where the 
control group remained untreated were relatively rare.  We identified 12 studies where 
the control group and treatment group were followed up after treatment had ended and 
in which participants in the control group remained untreated.  Follow up durations 
ranged from 3 months to 12 months.  One study reported follow up data at 3 months, 
6 months, and 12 months (Silverman, Kurtines, Ginsburg, Weems, Rabian, et al., 
1999).   Six studies reported follow up data before 6 months (Deblinger, Stauffer, & 
Steer, 2001; Gallagher, Rabian, & McCloskey, 2004; King, Tonge, Mullen, et al., 
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2000; Misfud & Rapee, 2005; Silverman et al.,1999; Williams et al., 2009).  For 
follow up at less than 6 months the effect size was moderate (see Table 2).  Four 
studies reported follow-up data at 6 months (Dadds, Spence, Holland, Barrett, & 
Laurens, 1997; Hudson et al., 2009; Ollendick et al., 2009; Silverman et al., 1999) and 
for these the overall effect size of treatment was not significant.   Three studies 
reported follow up data at 9 to 12 months (Hayward et al., 2000; Kendall, Hudson, 
Gosch, Flannery-Schroeder, & Suveg, 2008; Silverman et al., 1999); the effect size 
for treatment at 9 to 12 month follow up was not significant.     
What is the Effectiveness of Generic CBT Compared with Disorder–Specific 
CBT for Anxiety in Children and Young People?   
We identified 22 studies which examined generic treatments for anxiety in 
children and/or young people. Two of these studies recruited children with elevated 
levels of anxiety on generic anxiety measures (Barrett et al., 2001; Misfud & Rapee, 
2005).  Four of the studies recruited children with any anxiety disorder including 
OCD and PTSD (Hudson et al., 2009; Lyneham & Rapee, 2006; Rapee et al., 2006; 
Woods et al., 2009).  The other 16 trials mainly recruited children with separation 
anxiety disorder (SAD), social phobia, and generalized anxiety disorder (GAD; or 
over-anxious disorder or avoidant disorder), with some explicitly excluding children 
with OCD, PTSD, and specific phobias, and others recruiting children with all anxiety 
disorders, but only finding those with SAD, social phobia, and GAD.  Twenty seven 
trials recruited children and young people who met diagnostic criteria for a specific 
anxiety disorder (PTSD = 9, social phobia = 9, OCD = 5, specific phobias = 3, school 
refusal/anxiety = 2).    
We calculated effect sizes for CBT which was generic and for CBT which was 
targeted at a specific anxiety disorder (Table 2).  The overall effect size for generic 
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CBT treatment of anxiety disorders in children and/or young people was moderate.    
The overall effect size of disorder specific CBT for children and adolescents with 
anxiety was medium to large. We next calculated effect sizes for treatment of 
different diagnostic categories.  There were 9 randomized controlled trials of CBT for 
PTSD in children and young people.  The trials for PTSD were highly variable.  Some 
studies identified groups of children exposed to the same or closely related chronic 
stressors (e.g. war and conflict, sexual abuse) or to a specific environmental stressor 
(e.g. tsunami or earthquake). Other trials recruited children and young people where 
PTSD had been diagnosed following a wide range of different traumatic events.   
Studies of PTSD treatments also used various methods of randomization, including 
cluster randomization, and a very wide range of outcome measures.   The overall 
effect size for CBT for PTSD was moderate.    
We identified five RCTs of CBT for OCD in children and young people.  
OCD trials were generally of high quality, used clear diagnostic criteria to identify 
OCD (invariably the ADIS), treated highly co-morbid participants, and all used the 
same well-validated and standardized measures of symptoms (the CY-BOCS).  The 
overall effect size for OCD was very large and markedly larger than effect sizes for 
CBT in general or psychotherapy for anxiety overall.  This result is similar to that 
reported by Hofmann and Smits (2008) in their meta-analysis of CBT for adults with 
anxiety disorders.  
There were nine trials which evaluated CBT for social phobia in children and 
young people. All of these trials were of group CBT for social phobia. The mean 
effect size for the treatment of social phobia was moderate to large.  There were 
insufficient number of trials which focused on other specific anxiety disorders to 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
Running head: PSYCHOTHERAPY FOR ANXIETY IN CHILDREN 
 
 22
warrant separate analysis (3 trials reported on specific phobias and 2 on school 
anxiety).   
What is the Effect of Child Age on Effectiveness of Psychological Treatment for 
Anxiety in Children and Adolescents?  
The majority of studies included both children and adolescents in their 
samples.  We identified 20 studies which included only children (i.e. those 13 and 
below) and 6 studies which only recruited adolescents with anxiety (i.e. those aged 
over 13 years).  The mean effect size for children was moderate in size and the mean 
effect size for adolescents was very large, though with very wide confidence intervals.  
Table 3 shows the effect sizes associated with treatments for children and for 
adolescents.   
Table 3 about here 
We also examined the effect of age by classifying studies according to the 
mean age of their sample.  Two studies examined the effect of psychological 
treatment for trauma in children aged 4 to 5 years.  The mean effect size was small 
and was not significant; -0.28 (95% CI -0.90, 0.35).  Three studies reported that the 
mean age of participants was 7 to 8 years; the mean effect size of these studies was -
0.69 (95% CI -1.11, -0.26).  The largest group of studies (N = 19) reported that the 
mean age of participants was 9 to 10 years.  For this group the mean effect size was 
small; -0.29 (95% CI -0.51, -0.06).   Seven studies reported a mean age of participants 
between 11 and 12 years and the mean effect size was medium to large, -0.77 (95% 
CI -1.26, -0.29).  Four studies with a mean age of 13 to 14 had an overall effect size 
which was very large and which was significantly greater than zero; -2.13 (95% CI -
2.79, -1.48).  Finally 5 studies reported a mean age of 15 or older; their overall effect 
size was large, -1.21 (95% CI -2.35, -0.06).  Thus on the basis of dividing the sample 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
Running head: PSYCHOTHERAPY FOR ANXIETY IN CHILDREN 
 
 23
into children and adolescents, and by taking the mean age of the sample, the effect 
size of treatment for adolescents with anxiety was large and the effect size of 
treatment of children (i.e. under 13 years) was small to medium.  The data suggest 
that treatment of younger children is associated with smaller effect sizes.   
What is the Impact of Treatment Delivery on the Effectiveness of Psychotherapy 
for Child and Adolescent Anxiety? 
Parental involvement in treatment. 
 We classified parental involvement in treatment as ‘none’ (20 studies), 
‘minimal or educational only’ (11 studies), ‘some involvement’ (11 studies), and 
‘significant / extended involvement’ (18 studies).  The number of studies does not 
equal 55 because some trials included arms comparing parental versus individual 
treatment.  In each category of parental involvement the effect size of psychotherapy 
was medium and significant (see Table 3).  Thus there were minimal differences in 
the effectiveness of treatment with and without parental involvement suggesting that 
involving parents closely in their anxious child’s treatment is not associated with 
better outcomes.   
Effectiveness of group compared with individual treatment. 
Psychological therapy for anxiety disorders in children and adolescents can be 
delivered to individual participants or to groups of participants.  We classified 
treatments as individual or group interventions and examined their effect sizes (Table 
3). Three trials compared individual to group interventions (Barrett, Healy-Farrell, & 
March, 2004; Flannery-Schroeder & Kendall, 2000; Spence et al., 2006).  Thirty four 
studies compared group psychotherapy to a control condition. The effect size for 
group psychotherapy was medium.  Twenty seven studies compared individual 
psychotherapy for anxiety to a control condition and the effect size was large.  We 
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then calculated the effect size of group and individual CBT.  The effect size of group 
CBT was medium and the effect size of individual CBT was large (see Table 3).   
Number of hours of treatment. 
 We calculated the number of hours associated with each treatment.  Typically 
individual treatment sessions were one hour in duration.  The majority of studies (N = 
29) offered between 9 and 12 hours of treatment.  Five studies had treatment of 1 to 4 
hours, 6 studies offered 5 to 8 hours, 10 studies offered 13 to 16 hours, and 5 studies 
offered between 17 to 20 hours.  Table 3 shows the effect sizes associated with 
treatments of varying durations.  Treatments with between 1 to 4 hours had a non-
significant effect size.  The effect size for treatments of 5 to 8 hours was small and 
statistically significant.  Effect sizes for treatments of more than 9 hours were 
moderate to large.  Confidence intervals were above zero in all cases except for 
treatments lasting between 1 to 4 sessions.  The effect sizes therefore suggest that 
providing 5 or more sessions leads to at least small or moderate treatment effects.   
Moderate to large treatment effects are associated with 9 or more sessions of 
treatment.   
Discussion 
This meta-analysis provides an overview of randomized controlled trials of 
psychological therapies for children and adolescents with anxiety disorders.  This is a 
changing field with new methods of delivery (e.g. internet, bibliotherapy, email) 
being developed to meet the needs of different populations and client groups (e.g. 
young people with an autistic spectrum disorder). To our knowledge it is the first 
quantitative review which includes all anxiety disorders and which includes a range of 
psychological interventions.  There are some elements of psychological therapy which 
preclude the use of the most stringent trial designs; i.e. psychological therapy cannot 
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be delivered by therapists who are blind to the treatment they are delivering and thus 
double-blind designs cannot be used.  However, the quality assessment of the studies 
we reviewed suggests that the methodological quality of trials has improved; in 
particular, recent trials tend to conform to CONSORT reporting requirements, have 
much greater clarity about how participants are randomized, and include all 
randomized participants in their analysis and not only those who remain in treatment, 
and adhere to protocol.   
The results of this meta-analysis are broadly in line with those of previous 
reviews although we have included a significantly larger number of studies. In 
particular the overall effect size for psychotherapy vs. a control condition was very 
similar to those reported in previous meta-analyses (James et al., 2005; In-Albon & 
Schneider, 2007; Silverman et al., 2008).  In addition, we compared the effect of 
psychotherapy when compared to both passive and active control conditions.  The 
results provide strong evidence that psychological treatment of anxiety disorders in 
children and young people is associated with symptomatic change which is 
significantly greater than in participants randomized to an active psychological 
control condition.  This is an extremely important finding to have confirmed, 
especially as studies are more numerous and study designs become more robust.  
However, the effect size of psychological therapy when compared to an active control 
condition was small and thus we can state with confidence that treatment development 
and refinement is highly important if we are to maximize treatment efficacy. 
The nature of a meta-analytic review demands that the characteristics of 
individual studies are subsumed within an over-arching methodology which applies to 
all included studies.  The aim is to identify the broad picture rather than to highlight 
findings and strengths of individual studies.  We imposed some methodological 
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criteria in selecting studies to increase the potential validity of the results.  Thus we 
only included randomized trials and we rated the methodological quality of trials.  
The exclusion of lower quality studies increases the validity of the meta-analysis.  In 
addition we identified one outcome measure for each study before we extracted the 
data for meta-analysis.  This was always the child or young person’s self report of 
their symptoms.  This has some advantages but relies on the subjective accounts of 
children and young people, presents a relatively limited perspective on outcomes, may 
not reflect important aspects of functioning, and may give more conservative 
estimates of change.  Therefore the outcome measures used in this meta-analysis do 
not necessarily represent the outcome measure which trial authors themselves would 
have selected, and in some cases they may under-estimate the treatment effect.  
The vast majority of trials included in the meta-analysis assessed a variant of 
cognitive behavior therapy for anxiety.  Thus, the results of the meta-analysis are 
almost all attributed to the effects of CBT for anxiety.  Our data suggest that CBT for 
children and adolescents with anxiety is effective when compared to a passive (no 
treatment group) or an active control group.   CBT has clearly demonstrated that it is 
effective as a method of treating anxiety disorders and the positive effects of CBT 
may make it increasingly difficult to attract scarce research funding to evaluate other 
therapy methods.   Within CBT there remain many areas of uncertainty.  For example, 
our data suggest that disorder- specific CBT has a larger effect size than generic CBT.   
However, few studies of generic CBT include children with OCD or PTSD (n=4), and 
relatively few include children with specific phobias (n=6).  Thus the only disorder 
that is seen both specifically and generically is social phobia.  Furthermore there are 
no specific treatment trials for GAD (or OAD or avoidant disorder), or for SAD.  
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Thus there is a confound between the specificity of treatment and the anxiety disorder 
being treated.  
In our meta-analysis we also compared the effectiveness of different methods 
of delivering treatment.  The range of studies reviewed included a wide range of 
treatment delivery methods and this partly reflects the desire of clinical researchers to 
adapt treatments to best suit children and young people, to reach the maximum 
number of children with anxiety disorders, as well as the heterogeneous nature of 
anxiety disorders in children and young people.  Thus we compared effect sizes 
associated with group and individual treatment, degree of involvement of parents in 
treatment, generic anxiety treatment and disorder specific treatments, different 
treatment length, and different age bands of children and young people.  There are 
some problems with multiple testing in this way so we consider our sub-group results 
to be indicative.  However, with that caveat, the data suggest that individual treatment 
for anxiety is associated with a larger effect size than group treatment for anxiety, that 
disorder specific treatment is associated with a larger effect size than generic 
treatment for anxiety, that parental involvement is not associated with increased 
effectiveness of treatment, that longer durations of treatment tended to have larger 
effect sizes than shorter durations, and that older children and adolescents reported 
larger treatment effects than young children.  Ishikawa et al., (2007) found that 
treatments of more than 11 sessions were more effective than shorter treatment.    
The results of this meta-analysis suggest that there is a potential trade-off 
between the effect size of treatment and the resources required to deliver treatment; - 
longer and individual treatments achieved larger effect sizes than shorter or group 
based treatments.   In addition, the very small number of studies which incorporated a 
true follow up condition (i.e. where the treated group was compared to an untreated 
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group at follow-up) makes it very difficult to assess the longevity of changes 
following treatment.  This is a serious ethical and practical problem for which it is 
hard to find a solution but which may be partly ameliorated by the use of an active 
control condition (as opposed to a waitlist control condition).   
We found no evidence that parental involvement in therapy enhances 
treatment outcome and this is consistent with previous reviews (In-Albon & 
Schneider, 2007; Ishikawa et al., 2007; James et al., 2005, Silverman et al., 2008).   
However, as most of the treatments were CBT it is possible that parental involvement 
adds benefit to non-CBT interventions for child anxiety (Dowell & Ogles, 2010), or 
that there are certain types of anxiety for which parental involvement is particularly 
important (e.g. school refusal; Heyne et al., 2002).  It is also possible that parental 
involvement is more important for young children than for older children and 
adolescents or that it is most important for children whose parents are also anxious 
(see Kendall et al., 2008).  It certainly appears that the role of parental involvement is 
complex and may need to change over time and be sensitive to the needs and 
presentations of both children and their parents (Cobham, Dadds, Spence, & 
McDermot, 2010). The limitation of any generic meta-analysis is that these fine 
grained distinctions cannot be explored but these areas provide important questions 
for future treatment trials.    
The issue of parental involvement in treatment for child anxiety overlaps with 
questions around the extent to which children of different ages benefit differentially 
from therapy.  The data we extracted suggest that degree of symptom change reported 
by younger children was smaller than that reported by older children.  This may be 
because older children and teenagers are better able to engage in psychological 
therapy in general, or because they have the cognitive and interpersonal skills to 
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engage in CBT specifically.  Alternatively, or perhaps as well as, older children and 
teenagers may be better able to self report their symptoms of anxiety.   
These sub-group findings provide many diverse directions for future research 
in the treatment of anxiety disorders in children and young people and suggest other 
important questions.  The current standards of design, scope, and reporting of RCTs 
favor large scale, multi-site trials which are expensive and complex.  One the other 
hand the field is still developing rapidly and there is a need for smaller trials to 
establish if new treatments and new methods of delivering treatment are acceptable, 
feasible, safe, and potentially effective, in advance of any definitive trials and meta-
analyses. For example, there are a range of methods of delivering therapy through 
harnessing technology (internet and email) and via different professionals (e.g. 
teachers) as well as parents. It is not clear how effective these methods are compared 
to delivery by trained and expert therapists.  At present the number of studies in each 
of these areas is too small to allow meaningful comparison but it may become 
possible to integrate data through systematic reviewing and meta-analysis from 
studies as they accumulate over time.  In some areas, e.g. OCD, there is a consensus 
about appropriate outcome measures, including primary outcome measures, and also 
including methods of establishing diagnosis, and the use of multiple informants.  
Other areas, e.g. PTSD, present a much more heterogeneous picture, with multiple 
outcome measures, many different methods of treatment, and a wide range of 
contexts.   
Overall we found that the quality of research designs has improved although 
many rudimentary design errors are still common.  In our quality coding we found 
that studies still tend to be under-powered and fail to identify their primary outcome.  
Randomization processes may be open to bias and procedures for blinding and 
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assessing the success of blinding are rarely reported.  Of particular note was the 
almost complete absence of reporting the adverse effects of psychological therapy.  
This is presumably due to the assumption that psychological therapy cannot be 
harmful to participants but this assumption is questionable and at the least requires 
confirmation.  Our funnel plots suggest that studies which are of a higher 
methodological quality have the same overall effect sizes and that poor quality is not 
associated with the effect size of studies.   
There are clearly many more questions to address in this research field and 
probably far too many questions for the available resources.  There is therefore a need 
to prioritize research questions and to try to target human and financial resources.  
Overall, it would be helpful to identify which questions are sufficiently important to 
warrant the scale of funding required for a definitive study and which questions can 
be adequately resolved with smaller, cheaper, local studies of high quality.  
Researchers are likely to have many different and conflicting views but we see a small 
number of over-arching issues.  First future trials should include cost effectiveness 
and ITT analysis.  Second, the design, execution, and reporting of trials should be 
congruent with CONSORT reporting standards and in particular should include 
monitoring and reporting of adverse events of psychological therapy.  Third, trials 
should include an active control condition (rather than a passive waitlist control) and 
they should, if at all possible, include a follow-up period in which the control group 
does not receive the target intervention.    
Conclusions 
Anxiety disorders in children can be treated effectively and there is sufficient 
evidence to recommend psychological therapy, specifically behavioral or cognitive 
behavioral therapy.  The current evidence is adequate to provide broad guidance for 
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service development and service delivery as well as in guiding parents and young 
people themselves.  However the moderate effect sizes derived from treatment studies 
mean that there is considerable room for improvement in treatment outcomes.   
The complexity of the field also means that there are insufficient data to 
examine many complex questions about treatment planning and delivery, for example 
possible interactions between the age of the child or young person and the 
effectiveness of involving their parent in treatment, or using different methods of 
delivery.  In the absence of these fine-grained data clinical decisions about how to 
treat individual children and young people is best guided by integrating research 
evidence with clinical judgment and specialist knowledge of systemic and 
developmental theory, and critically, the preferences of children, adolescents, and 
their parents.   
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Table 1. Characteristics of individual studies included in the meta-analysis 
Authors Type of sample Age 
range 
 N  Type of anxiety % 
girls 
Experimental 
treatment 
Control group Outcome Treatment 
Standardized ES 
Ahmed et al. 
(2009) 
Clinical 6-16 33 PTSD 60.6 Indiv EMDR Wait list PTSS-C EMDR 0.07 
Baer & Garland 
(2005) 
Clinical 13-18 12 Social phobia 58.3 Group CBT Wait list SPAI CBT -1.12 
Barrett (1998) Mixed 7-14 60 Mixed anxiety 
disorders 
46.7 Group CBT 
Group CBT + family 
Wait list FSSC-R Group CBT -1.56;  
Group CBT +  family 
2.42 
Barrett et al. (1996) Mixed 7-14 79 Mixed anxiety 
disorders 
43.4 Indiv CBT 
Indiv CBT + family 
Wait list RCMAS CBT -0.40;  
CBT  family 0.92 
Barrett et al. (2001) Community 
screened  
7-19 204 Raised anxiety 
levels 
47.4 Group CBT Wait list RCMAS Group CBT -0.65 
Barrett et al. (2004) Health service 
screened  
7-17 77 OCD 49.4 Group CBT 
Indiv CBT 
Wait list CYBOCS Group CBT -2.54;  
Indiv CBT -2.73 
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Beidel et al. (2000) Clinical 8-12 67 Social phobia 61.5 Group CBT Non-specific 
(Testbusters) 
SPAI CBT -.89  
Berger & Gelkopft 
(2009) 
School sample 9-15 182 PTSD 43.4 CBT group 
(ERASE) 
Wait list UCLA PTSD index CBT group -1.27 
Bolton et al. (2008) Clinical 8-17 20 OCD 30.0 Individual ERP  Wait list CYBOCS ERP -1.46 
Celano et al. (1996) Clinical 8-13 32 PTSD 100.0 Psychotherapy with parent 
(RAP) 
Treatment as usual CITES 
Children’s Impact of 
Traumatic Events Scale 
RAP  0.20 
Chalfant et al. 
(2007) 
Clinical 8-13 47 Mixed anxiety 
disorders with 
ASD 
25.5 Group family CBT Wait list RCMAS CBT -3.29 
Chemtob et al. 
(2002) 
Clinical 6-12 32 PTSD 68.8 Indiv EMDR Wait list Child Reaction Index EMDR -0.36 
Cohen et al. (2004) Clinical 8-14 229 PTSD 79.0 Individual TF CBT with 
parent 
Child centred 
therapy 
K-SADS PTSD Scale – 
Re-experiencing 
CBT-0.49 
Cohen et al. (1996) Clinical 3-6 67 PTSD 58.0 Individual TF CBT with Nondirective Child Sexual Behavior CBT -0.58 
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parent supportive therapy Inventory 
Cohen et al. (1998) Clinical 7-14 49 PTSD 69.0 Individual TF CBT with 
parent  
Nondirective 
supportive therapy 
Child Sexual Behavior 
Inventory 
CBT -0.23 
Dadds et al. (1997) Community 
screened  
7-14 128 Mixed anxiety 
disorders  
72.7 Group CBT with parent Monitoring group RCMAS CBT 0.01 
Deblinger et al. 
(2001) 
Clinical 2-8 44 PTSD 61.0 Group CBT with parent Supportive 
therapy 
K-SADS PTSD Scale – 
Re-experiencing 
CBT 0.06 
Flannery-Schroeder 
& Kendall (2000) 
Community 
screened  
8 -14 37 Mixed anxiety 
disorders 
48.3 Individual CBT  
Group CBT 
 
Wait list RCMAS Individual  CBT -1.05;  
Group l CBT -0.80 
Freeman et al. 
(2008) 
Mixed 5-8 42 OCD 57.0 Family CBT Relaxation 
training 
CYBOCS CBT -0.66 
Gallagher et al. 
(2004) 
Community 
screened  
8-11 23 Social phobia 52.2 Group CBT Wait list SPAI CBT -0.71 
Gelkopft & Berger 
(2009) 
School sample 12-14 114 PTSD 0.0 Group CBT 
 
Wait list UCLA PTSD index CBT -0.69 
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Ginsburg & Drake 
(2002) 
Community 
screened  
14-17 12 Mixed anxiety 
disorders 
83.3 Group CBT Group attention-
support 
SCARED CBT -0.24 
Hayward et al. 
(2000) 
Community 
advert 
14-17 70 Social phobia 100.0 Group CBT Untreated SPAI CBT -0.28 
Hudson et al. 
(2009) 
Mixed methods 7-16 112 
 
Mixed anxiety 
disorders 
44.2 Group CBT Group support SCAS CBT  0.63 
Jordans et al. 
(2010) 
School sample 11-14 325 PTSD 48.6 Psychosocial group 
intervention 
Wait list SCARED-5 Psychosocial group 
intervention 0.09 
Kemp, et al.,  
(2009) 
Clinical 6-12 27 PTSD 44.4 Individual EMDR Wait list PTS-RI EMDR -1.18 
Kendall (1994) Community 
screened  
9 -13 47 Mixed anxiety 
disorders 
44.0 Individual  CBT Wait list RCMAS CBT -0.86 
Kendall et al. 
(1997) 
Mixed 9-13 94 Mixed anxiety 
disorders 
38.0 Individual  CBT Wait list RCMAS CBT -0.58 
Kendall et al. 
(2008) 
Community 
screened 
7-14 107 Mixed anxiety 
disorders 
44.0 Individual CBT 
Individual CBT + family 
Family based 
education/support 
attention 
MASC CBT -0.13;  
CBT + family-0.10 
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King et al. (1998) Mixed 5-15 34 School refusal 47.1 Individual CBT + 
parent/teacher behavior 
management 
Wait list RCMAS CBT -0.46 
King et al. (2000) Clinical 5-17 36 PTSD 69.4 Individual CBT 
Individual CBT + family 
Wait list ADIS PTSD CBT -1.09;  
CBT + family -1.19 
Last et al. (1998) Mixed 6-17 56 School refusal 37.0 Individual CBT  Attention placebo RCMAS CBT -0.58 
 
Layne et al. (2008) Community 
screened  
13-18 127 PTSD 61.6 Group integrated 
psychotherapy  
Psycho-education PTSD Reaction Index Psychotherapy -0.22 
Lyneham & Rapee 
(2006) 
Clinical 6-12 100 Mixed anxiety 
disorders 
49.0 CBT bib +  telephone 
CBT bib + email 
Wait list  
CBT bibliotherapy 
 
RCMAS CBT bib+phone -1.02  
CBT bib +  email -
0.71 
March & Spence 
(2009) 
Community 
advert (schools) 
7-12 73 Mixed anxiety 
disorders 
54.8 Internet CBT Wait list SCAS Internet CBT  -0.18 
Masia-Warner et al. 
(2005) 
Community 
screened  
13-17 35 Social phobia 74.2 Group CBT Wait list SPAI CBT -0.59 
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Masia-Warner et 
al.(2007) 
Community 
screened  
14-16 36 Social phobia 83.3 Group CBT  Attention placebo SPAI CBT-5.62 
 
Mendlowitz et al. 
(1999) 
Clinical 7-12 62 Mixed anxiety 
disorders 
57.4 Group CBT child  
Group CBT Parent  
Group CBT child + parent 
Wait list RCMAS CBT child  -0.18;  
CBT parent -0.18; 
CBT child+parent -
0.35 
Misfud & Rapee 
(2005) 
Community 
screened  
8-11 91 Raised anxiety 
levels 
59.0 Group CBT  Wait list SCAS CBT -0.35 
Muris et al. (2002) Community 
screened  
9-12 30 Mixed anxiety 
disorders 
66.7 Group CBT Psychological 
placebo 
No treatment 
STAI CBT -1.0 
Ollendick et al. 
(2009) 
Mixed 7-16 196 Specific phobia 54.6 Behavior therapy 
(one session therapy) 
Wait list 
Education support 
FSSC-R BT 0.01 
Ost et al. (2001) Clinical 7-17 60 Specific phobia 33.3 Individual BT (OST)  
Individual BT + parent 
Wait list RCMAS BT 0.06;  
BT + parent -0.24 
POTS (2004) Clinical 7-17 112 OCD 50.0 Individual CBT Placebo CYBOCS CBT -0.96 
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medication 
Rapee et al. (2006) Not stated 6-12 267 Mixed anxiety 
disorders 
39.6 Group CBT 
 
Wait list 
Bibliotherapy  
CBT 
SCAS CBT 0.14;  
 
Ruf et al. (2010) Clinical 7-16 26 PTSD 46.2 Narrative exposure 
therapy 
Wait list UCLA PTSD index Narrative exposure 
therapy -1.0 
Shortt et al. (2001) Community 
advert 
6-10 71 Mixed anxiety 
disorders 
61.0 Group CBT Wait list RCMAS CBT  -0.92 
Silverman, 
Kurtines et al. 
(1999) 
Mixed 6-16 41 Mixed anxiety 
disorders 
36.0 Group CBT Wait list RCMAS CBT  -0.57 
Silverman et al. 
(1999) 
Clinical 6-16 81 Specific phobia 46.7 Individual CBT 
Individual BT 
Education support RCMAS CBT -0.71;  
BT -0.18 
Smith et al. (2009) Clinical  8-18 24 PTSD 39.5 Individual CBT Wait list CPSS CBT -2.39 
Spence et al (2000) Clinical 7-14 50 Social phobia 38.6 Individual CBT 
Individual  CBT + parent 
Wait list RCMAS CBT -0.45;   
 CBT + parent -0.44 
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Spence et al. (2006) Clinical 7-14 72 Mixed anxiety 
disorders 
41.7 Group CBT 
Internet CBT 
Waitlist RCMAS CBT -0.71;  
Internet CBT -0.27 
Stein et al. (2003) Community 
screened  
10-11 126 PTSD 56.0 Group CBT Wait list RCMAS CBT -0.82 
Walkup et al. 
(2008) 
Clinical 7-17 215 Mixed anxiety 
disorders 
50.7 Individual CBT Placebo 
medication 
Pediatric Anxiety Rating 
Scale 
CBT -0.30 
Williams et al. 
(2009) 
Clinical 9-18 21 OCD 38.1 Individual CBT Wait list CYBOCS CBT -3.38 
Woods et al., 2009 Clinical 7-11 40 Anxiety 
disorders with 
ASD 
32.5 Family CBT Waitlist MASC CBT 0.03 
 
Notes: 
Type of disorder: PTSD – Post traumatic stress disorder, OCD – Obsessive compulsive disorder, ASD – Autistic spectrum disorder 
Experimental treatment: EMDR – Eye Movement Desensitisation and Reprocessing;  CBT – Cognitive Behavior Therapy, ERP – Exposure and 
response prevention; ERASE; RAP; TF CBT – Trauma focused CBT;  
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Outcome:  PTSS-C – Posttraumatic Stress Symptom Scale for Children; SPAI-C – Social Phobia and Anxiety Inventory for children, FSSC-R – 
Fear Survey Schedule Revised; RCMAS – Revised Children’s Manifest Anxiety Scale; CYBOCS – Children’s Yale-Brown Obsessive 
Compulsive Scale: CITES = Children’s Impact of Traumatic Events Scale, K-SADS, SCARED-5 – Screen for Child Anxiety Related Emotional 
Disorders; SCAS – Spence Children’s Anxiety Scale; PTS-RI – Post Traumatic Stress-Reaction Index, MASC – Multidimensional Anxiety 
Scale for Children, ADIS-C – Anxiety Disorder Interview Schedule for Children; CPSS –Child PTSD Symptom Scale, STAI – State-Trait 
Anxiety Inventory for Children. 
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Table 2:  Effect sizes associated with type of treatment for anxiety disorders 
 
 
Treatment group N of studies              Effect size            95% CI                     
    
All studies  55 -0.65 -0.82, -0.48 
        Passive control 39 -0.76 -0.97, -0.55 
       Active control 19 -0.35 -0.59, -0.11 
    
Follow up < 6 months 6 -0.68 -1.26, -0.10 
Follow up = 6 months 4 -0.19 -0.52,  0.14 
Follow up 9-12 months 3 -0.02 -0.38,  0.33 
    
Not CBT 7 -0.25 -0.57,  0.08 
All CBT 48 -0.66 -0.84, -0.48 
       CBT passive control 34 -0.77 -1.00, -0.55 
      CBT active control 14 -0.39 -0.64, -0.15 
    
Generic CBT 22 -0.53 -0.75,  -0.30 
Disorder specific CBT 27 -0.77 -1.03, -0.51 
     PTSD 9 -0.68 -0.99,  -0.37 
     OCD 5 -1.68 -2.55, -0.81 
    Social phobia 9 -0.79 -1.39, -0.19 
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Table 3: Effect sizes associated with child and treatment delivery factors 
 N of studies Effect size 95% CI 
Age    
     Child ≤ 13 years 20 -0.63 -0.96, -0.30 
     Adolescent ≥ 14 years 6 -1.38 -2.65, -0.11 
    
Parental  Involvement    
     None 20 -0.57 -0.83, -0.31 
     Minimal 11 -0.69 -1.06, -0.32 
     Some 11 -0.65 -1.03, -0.26 
    Significant/extensive 18 -0.63 -0.98, -0.27 
    
Delivery mode    
     Group 34 -0.57 -0.78, -0.36 
     Individual 27 -0.75 -1.00, -0.51 
    
     Group CBT 26 -0.58 -0.81, -0.36 
     Individual CBT 23 -0.85 -1.14, -0.56 
    
Duration of treatment (hours)    
     1-4 5 -0.02 -0.14, -0.19 
     5-8 6 -0.35 -0.66, -0.01 
     9-12 29 -0.77 -1.02, -0.51 
     13-16 10 -0.75 -1.17, -0.34 
     17-20 5 -0.65 -0.99, -0.32 
 
